PTGS2 and neoplasm: The development of Pt(IV) prodrugs with COX inhibitors in the axial position is a promising therapeutic approach due to the fact that the Pt(IV) prodrug’s ability to bind COX-2 will increase the selectivity of prodrugs for tumor cells in comparison with classical Pt(II) drugs.